OOIR: Observatory of International Research

Papers

(The H4-Index of Diabetology & Metabolic Syndrome is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Investigating CR1 as an indicated Gene for mild cognitive impairment in type 2 diabetes mellitus	138
The impact of obesity in hospitalized patients with COVID-19: a retrospective cohort study	126
The impact of metformin on myocardial hypertrophy: an updated systematic review, meta-analysis, and meta-regression of randomized controlled trials	113
Molecular cross-talk via extracellular vesicles for the characterization of young subjects with type 1 diabetes unravels new potential markers of insulin resistance and double diabetes	86
Plasma aryl hydrocarbon receptor associated with epicardial adipose tissue in men: a cross-sectional study	79
Unveiling the role of lipopolysaccharide-related genes in diabetic retinopathy: identification of key biomarkers and immune infiltration analysis	76
Correction to: Development of models to predict 10-30-year cardiovascular disease risk using the Da Qing IGT and diabetes study	75
Correction: Semaglutide restores astrocyte-vascular interactions and blood-brain barrier integrity in a model of diet-induced metabolic syndrome	73
The effect of metabolic dysfunction-associated fatty liver disease and diabetic kidney disease on the risk of hospitalization of heart failure in type 2 diabetes: a retrospective cohort study	69
Association between the triglyceride–glucose index and acute kidney injury in patients undergoing percutaneous coronary: a retrospective analysis of the MIMIC-IV database	67
Preclinical evidence of the effect of icariin on diabetic nephropathy: a systematic review and meta-analysis	62
Nature’s blueprint for sugar metabolism: translating bee and ant strategies into human diabetes therapies	61
Association between serum bilirubin and diabetic retinopathy: results from the NHANES 1999–2018 and Mendelian randomization study	58
Nomogram integrating serological markers and clinical parameters for predicting severe hepatic steatosis in patients with abnormal glucose metabolism	50
Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b	50
Reclassification of type 2 diabetes to type 1 diabetes in Asturias (Spain) between 2011 and 2020	50
Development and temporal external validation of a high-specificity XGBoost rule-in model for diabetes in middle-aged and older Korean adults	49
Identification of circulating inflammation cytokines as a mediator of gut microbiota and type 2 diabetes mellitus: a Mendelian randomization study	49
GRP78 protein metabolism in obese and diabetic rats: a study of its role in metabolic disorders	48
Global burden of chronic liver disease due to NAFLD from 2012 to 2021: A trend, decomposition, and health inequality analysis	47
Plin5: A potential therapeutic target for type 2 diabetes mellitus	47
Mesenchymal stem cells ameliorate inflammation and pyroptosis in diabetic cardiomyopathy via the miRNA-223-3p/NLRP3 pathway	46
Higher adherence to the EAT–lancet diet is associated with reduced risk of metabolic dysfunction–associated steatotic liver disease: a 5-year middle eastern cohort study	45
Exosomal miR-20a-5p derived from renal tubular epithelial cells regulates podocyte cytoskeletal remodeling via targeting myosin X in diabetic kidney disease	44
Association of the stress hyperglycemia ratio with coronary artery disease complexity as assessed by the SYNTAX score in patients with acute coronary syndrome	42

Association of caffeine intake with all-cause and cardiovascular mortality in diabetes and prediabetes	42
17-year follow-up of association between telomere length and all-cause mortality, cardiovascular mortality in individuals with metabolic syndrome: results from the NHANES database prospective cohort s	41
Non-linear association of a novel inflammation-lipid composite marker CRP/HDL with insulin resistance and type 2 diabetes: findings from a comprehensive national cross-sectional study	39
MRI adipose tissue segmentation and quantification in R (RAdipoSeg)	38
Effect of atherogenic index of plasma and triglyceride-glucose index on early neurological deterioration of patients with large artery atherosclerotic ischemic stroke	38
From background diabetic retinopathy to its proliferative stage. What is the role of gut microbiota in the trajectory of DR? a Mendelian randomization study with mediation analysis	38
Sex/race categories, social determinants, and cardiovascular events in Brazilian adults with diabetes: a longitudinal analysis from ELSA-Brasil	37
Associations of estimated glucose disposal rate and overactive bladder and the potential mediating role of systemic inflammation: NHANES 2005–2018	36
The association of changes in the Chinese visceral adiposity index and cardiometabolic diseases: a cohort study	36
Metformin plus lifestyle interventions versus lifestyle interventions alone for the delay or prevention of type 2 diabetes in individuals with prediabetes: a meta-analysis of randomized controlled tri	34
Integrating exosome wide associations study and Mendelian randomization identified causal miRNAs for type 2 diabetes mellitus and its complications	34
Association between various blood glucose variability-related indicators during early ICU admission and 28-day mortality in non-diabetic patients with sepsis	34
Association between estimated glucose disposal rate with the all-cause and cause-specific mortality among the population with cardiometabolic syndrome	34
Triglyceride glucose index–body mass index as a predictor of coronary artery disease severity in patients with H-type hypertension across different glucose metabolic states	34